Free provider profile
RENEE STEWART
Need more providers like RENEE STEWART?
See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.
Rep intel
What RENEE STEWART prescribes and who else does
Top Medicare Part D drugs by claims (public CMS data):
- Glatiramer Acetate
- Kesimpta Pen
- Copaxone
- Tecfidera
- Betaseron
Your next referral list starts here
Provider + market indicator
A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.
Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.
Practice contact card
Practice phone
402-559-8600
Fax
402-559-5010
Practice address
4242 FARNAM ST STE 650, OMAHA, NE, 68131
- Registry updated
- 2018-07-16
- NPI issued
- 2018-07-16
- RepVector retrieved
- 11/20/2026
A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.
Registry record
Source: CMS NPPES registry.
4242 FARNAM ST STE 650, OMAHA, NE, 68131
402-559-8600
Single practice location
Enumerated 2018-07-16
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 8 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,807
Medicare patients
127
Part D drug cost
$2,277,471
Brand-name share
16.1%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Kesimpta Pen (Ofatumumab) | 53 | $439,232 |
| Tecfidera (Dimethyl Fumarate) | 37 | $338,296 |
| Betaseron (Interferon Beta-1b) | 26 | $224,260 |
| Copaxone (Glatiramer Acetate) | 38 | $198,538 |
| Avonex Pen (4 Pack) (Interferon Beta-1a) | 24 | $181,412 |
| Rebif (Interferon Beta-1a/Albumin) | 13 | $130,771 |
| Glatiramer Acetate (Glatiramer Acetate) | 58 | $123,956 |
| Aubagio (Teriflunomide) | 14 | $123,724 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Latest Medicare Part B billing
CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.
Loading the latest published CMS billing file…
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
Checking Open Payments…
Industry payments across NE — which companies pay providers there.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.
